BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mehrara E, Forssell-Aronsson E. Analysis of inter-patient variations in tumour growth rate. Theor Biol Med Model 2014;11:21. [PMID: 24885724 DOI: 10.1186/1742-4682-11-21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li D, Finley SD. Mechanistic insights into the heterogeneous response to anti‐VEGF treatment in tumors. Comp Sys Onco 2021;1. [DOI: 10.1002/cso2.1013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yu YL, Yang YJ, Lin C, Hsieh CC, Li CZ, Feng SW, Tang CT, Chung TT, Ma HI, Chen YH, Ju DT, Hueng DY. Analysis of volumetric response of pituitary adenomas receiving adjuvant CyberKnife stereotactic radiosurgery with the application of an exponential fitting model. Medicine (Baltimore) 2017;96:e4662. [PMID: 28121913 DOI: 10.1097/MD.0000000000004662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
3 Andereggen L, Vajtai I, Widmer HR, Raabe A, Andres RH. Rapid Recurrence of a Benign Meningial Perineurioma. World Neurosurg 2015;84:2074.e1-3. [PMID: 26072455 DOI: 10.1016/j.wneu.2015.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Pamir MN, Özduman K. Current decision-making in meningiomas. Handb Clin Neurol 2020;169:229-52. [PMID: 32553292 DOI: 10.1016/B978-0-12-804280-9.00015-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Muñoz-Martínez S, Sapena V, Forner A, Nault JC, Sapisochin G, Rimassa L, Sangro B, Bruix J, Sanduzzi-Zamparelli M, Hołówko W, El Kassas M, Mocan T, Bouattour M, Merle P, Hoogwater FJH, Alqahtani SA, Reeves HL, Pinato DJ, Giorgakis E, Meyer T, Villadsen GE, Wege H, Salati M, Mínguez B, Di Costanzo GG, Roderburg C, Tacke F, Varela M, Galle PR, Alvares-da-Silva MR, Trojan J, Bridgewater J, Cabibbo G, Toso C, Lachenmayer A, Casadei-Gardini A, Toyoda H, Lüdde T, Villani R, Matilla Peña AM, Guedes Leal CR, Ronzoni M, Delgado M, Perelló C, Pascual S, Lledó JL, Argemi J, Basu B, da Fonseca L, Acevedo J, Siebenhüner AR, Braconi C, Meyers BM, Granito A, Sala M, Rodríguez-Lope C, Blaise L, Romero-Gómez M, Piñero F, Gomez D, Mello V, Pinheiro Alves RC, França A, Branco F, Brandi G, Pereira G, Coll S, Guarino M, Benítez C, Anders MM, Bandi JC, Vergara M, Calvo M, Peck-Radosavljevic M, García-Juárez I, Cardinale V, Lozano M, Gambato M, Okolicsanyi S, Morales-Arraez D, Elvevi A, Muñoz AE, Lué A, Iavarone M, Reig M. Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP Rep 2021;3:100260. [PMID: 33644725 DOI: 10.1016/j.jhepr.2021.100260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Stensjøen AL, Berntsen EM, Jakola AS, Solheim O. When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo. Clin Neurol Neurosurg 2018;170:38-42. [PMID: 29727799 DOI: 10.1016/j.clineuro.2018.04.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]